I received Dipl. Eng. degree in Pharmacy from the School of Pharmacy and Biochemistry, University of Zagreb, Croatia. I worked for my master degree in Pharmaceutical Technology at Pharmacology and Therapeutics Department, McGill University, Montreal, Canada. I obtained PhD (Doctorate Medicine-Pharmacy) from University of Zagreb, Croatia in 1994 for work completed under supervision of Prof SS Davis and Prof L Illum at the School of Pharmacy, University of Nottingham.
Following PhD, I took up postdoctoral position at the School of Pharmacy at Nottingham, and was subsequently appointed Lecturer in 2000, and Associate Professor in Advanced Drug Delivery in 2006. In 2019 I was promoted to Professor in Pharmaceutics at School of Pharmacy, University of Nottingham.
I held the Royal Society Industry Fellowship in 2007-2009.
I am now director of EPSRC Centre for Doctoral Training in Advanced Therapeutics and Nanomedicines, and PI and Director of 2018 funded Centre for Doctoral Training in Transformative Pharmaceutical Technologies at University of Nottingham, University College London, SSPC Centre for Pharmaceuticals in Ireland, and a consortium of pharmaceutical and healthcare industry partners.
My research lies at the interface of physicochemical characterisation and biological performance of drug delivery systems. Representative recent examples include studies on transport of nanoparticles into/across cells, and events at epithelium and at cell membrane (Molecular Pharmaceutics 2014, Scientific Reports 2018, Molecular Pharmaceutics 2019, Biochimica et Biophysica Acta-Bioenergetics 2019), ligand mediated delivery of colloidal polymeric systems (J Controlled Release 2012, 2013, 2020, Small 2013, Science Advances 2015) and 'cells in matrices' (J Biotechnology 2009, Bioconjugate Chemistry 2019).
My research funding also includes a portfolio of industry-sponsored projects with NittoDenko Japan, UCB Celltech, Biocompatibles, AstraZeneca, Vectura, MedImmune, Baxter, Critical Pharmaceuticals, Archimedes, Honda, and GSK.
Pharmaceutics lead on Gastrointestinal and liver diseases, and Central nervous system modules of MPharm course, and Advanced drug delivery, and Science in industry modules of MSci course.
My research lies at the interface between physicochemical characterisation and biological properties of drug delivery systems. Recent representative examples include studies on transport of… read more
ALAZZO, ALI, AL-NATOUR, MOHAMMAD AHMAD, SPRIGGS, KEITH, STOLNIK, SNJEZANA, GHAEMMAGHAMI, AMIR, KIM, DONG-HYUN and ALEXANDER, CAMERON, 2019. Investigating the intracellular effects of hyperbranched polycation-DNA complexes on lung cancer cells using LC-MS-based metabolite profiling MOLECULAR OMICS. 15(1), 77-87 VASILIKI PARASKEVOPOULOU, VERONICA GARCIA ARTIAGA, RACHEL ROWLINSON, G. SEBASTIAAN WINKLER, PAUL GELLERT, SNOW STOLNIK, ROSS OVERMAN and FRANCO H. FALCONE, 2019. Introduction of a C-terminal hexa-lysine tag increases thermal stability of the LacDiNac binding adhesin (LabA) exodomain from Helicobacter pylori Protein Expression and Purification. 163, 105446
SHERMAN, HARRY G., HICKS, JACQUELINE M., JAIN, AKHIL, TITMAN, JEREMY J., ALEXANDER, CAMERON, STOLNIK, SNOW and RAWSON, FRANKIE J., 2019. Mammalian-Cell-Driven Polymerisation of Pyrrole CHEMBIOCHEM. 20(8), 1008-1013
My research lies at the interface between physicochemical characterisation and biological properties of drug delivery systems. Recent representative examples include studies on transport of nanoparticles into or across cells of epithelium, events at epithelium and at cell membrane to achieve drug delivery (Molecular Pharmaceutics 2014, 2015, 2019, Scientific Reports, 2018, Biochimica et Biophysica Acta-Bioenergetics, 2019), ligand mediated delivery and polymeric systems (J Controlled Release 2012, 2013, 2020, Small 2013, Science Advances 2015, Nanoscale 2019) and 'cells in matrices' J Biotechnology 2009, Bioconjugate Chemistry 2019).